Medtec is a specialized exhibition dedicated to delivering solutions for medical device R&D and manufacturing. Its 20th edition will take place from September 1-3, 2026, and will relocate to a new venue: SNIEC (Pudong) N1-N4.
Visitor Badge can be applied in March 2026, the pre-registration is for free while the ticket will cost ￥100 onsite from September 1 to 3.
Background:
At the pivotal moment when the global medical device industry is undergoing a profound transformation from “scale expansion” to “high-quality development,” the Chinese market in 2026 is facing unprecedented structural opportunities and challenges. As the inaugural year of the “15th Five-Year Plan,” the industry has embarked on a new phase of value transformation, propelled by four key factors: targeted policy support, clustered technological breakthroughs, stratified demand evolution, and upgraded globalization paradigms. The market size is anticipated to expand steadily, reaching approximately RMB 1.08 trillion by 2026, with the industry’s growth paradigm comprehensively shifting from capital-driven to a dual-engine model powered by innovation and globalization.
The market and capital landscape are evolving in tandem. On one hand, domestic substitution has entered the “deep-water zone.” Bolstered by policy support and an “anti-involution” approach, leading companies with technological prowess are steadily expanding their market share. On the other hand, the “going global” strategy has evolved from mere product trade to encompassing global operations and standard exportation, marking it as an indispensable avenue for leading enterprises to cope with domestic centralized procurement pressures and explore new growth spaces. The capital market is experiencing a rational adjustment. In 2025, the medical device sector recorded 277 investment and financing transactions, with total funding surpassing 16.6 billion yuan. Capital is increasingly converging on mid-to-late-stage innovative projects that exhibit clear clinical value and viable commercialization paths. Vascular interventional consumables, surgical robots, and ophthalmic and aesthetic medical devices have risen as the three premier sectors for capital competition.
This forum is designed to bring together industry and investment experts to discuss how to accurately pinpoint high-value innovation pathways, optimize capital allocation efficiency, and establish a virtuous cycle of “clinical value – technological breakthroughs – capital empowerment – commercial success” amid the increasingly complex global competitive landscape. By doing so, it aims to assist China’s medical device industry in securing a more prominent foothold on the global innovation stage.
Participants:
- Medical device manufacturers
- Suppliers, consultants and other organizations serving the medical device industry
- Hospitals, universities and research institutions
Agenda:
| Time | Topic |
| 9:50-10:00 | Moderator Remarks |
| 10:00-10:30 | Analysis of the Overall Investment and Financing Trends in the Medical Device Industry for 2026 |
| 10:30-11:00 | Analysis of Typical Cases in Medical Device Investment and Financing |
| 11:00-11:30 | Key Focus Points for BD/M&A in Large Enterprises |
| 11:30-12:00 | Path Selection and Value Realization for Medical Device Companies in IPO |
| 12:00-12:10 | Conference Close |
Background:
As China’s medical device industry continues to bolster its innovation capabilities and domestic market competition intensifies, global expansion has transitioned from a mere “option” to a “necessity” for numerous companies seeking sustainable growth. Currently, Chinese medical device companies are navigating a pivotal shift from mere “product export” to “brand globalization” and even “value chain expansion.” Their export product mix is continually refining, transitioning from conventional low-value consumables and equipment to high-value-added segments like advanced imaging, life support systems, and cutting-edge interventional products. Market reach has progressively broadened from emerging economies to mainstream regulated markets with the most stringent compliance standards, including Europe and the United States. Amidst this grand wave of global expansion, companies are confronted with a host of distinctive and intricate challenges: formidable regulatory compliance barriers, the gap between clinical trials and market commercialization, the trial of global supply chain robustness, and the profound complexities of localized operations. Meanwhile, the restructuring of global industrial chains, the accelerated regionalization of supply chains, and the deepening of digital transformation are presenting historic opportunities for enterprises possessing core competitive strengths. The age of “going solo” has given way to “ecosystem integration and collaborative globalization”, as the key to breakthroughs.
This conference focused on the core challenges and development trends for medical device companies expanding overseas, delving into strategies for building compliant, agile, resilient, and intelligent global supply chain frameworks to aid Chinese medical device enterprises in surmounting the obstacles of international expansion.
Participants:
- Medical device manufacturers
- Suppliers, consultants and other organizations serving the medical device industry
- Hospitals, universities and research institutions
Agenda:
| Time | Topic |
| 9:50-10:00 | Moderator Remarks |
| 10:00-10:30 | How Can Domestic Medical Devices Ride the Waves in the Global Market |
| 10:30-11:00 | Strategic Breakthrough and Ecosystem Construction for Cardiovascular Intervention Going Global |
| 11:00-11:30 | Sharing Insights on Overseas Expansion Strategies |
| 11:30-12:00 | Exploring the Globalization Path of Chinese Medical Devices |
| 12:00-12:10 | Conference Close |